GOLF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Acushnet Holdings Corp (GOLF) is currently not an ideal buy for a beginner investor with a long-term strategy. The stock's valuation appears stretched, hedge funds are selling, and analysts have a neutral to cautious outlook due to valuation concerns. While the company has shown strong financial growth and a positive technical setup, the lack of strong catalysts and mixed sentiment from analysts suggests a 'hold' is more prudent at this time.
The technical indicators are showing bullish momentum. The MACD is positive and expanding, RSI is neutral at 77.174, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level of 98.064, with further resistance at 100.191.
The company reported strong Q4 2025 financials with revenue up 7.20% YoY and significant improvements in net income and EPS. Gross margin increased by 100.14% YoY. Analysts acknowledge solid demand, product cadence, and capital returns. The golf industry has positive momentum, as highlighted by analysts during the PGA Show.
Hedge funds are selling heavily, with a 165.41% increase in selling activity last quarter. Analysts are cautious about the stock's valuation, which is trading at over 16-times expected 2026 EBITDA. Tariffs and discretionary spending challenges remain headwinds. Insiders are neutral, and there is no recent congress trading data to indicate political confidence.
In Q4 2025, Acushnet Holdings reported revenue growth of 7.20% YoY to $477.22M. Net income improved significantly to -$34.9M, up 3027.33% YoY. EPS increased to -0.58, up 2800.00% YoY. Gross margin rose to 43.67%, up 100.14% YoY.
Analysts have mixed views. Roth Capital raised the price target to $102 but maintained a Neutral rating, citing balanced risk/reward. Jefferies raised the price target to $100 but also maintained a Hold rating, noting margin pressures and tough comps. Truist and Morgan Stanley highlighted positive industry momentum but expressed valuation concerns. JPMorgan upgraded the stock to Neutral from Underweight with a price target of $96, citing portfolio growth and pricing power.
